Back to Search
Start Over
Chloroquine differentially modulates coronary vasodilation in control and diabetic mice
- Source :
- British Journal of Pharmacology, British journal of pharmacology, vol 177, iss 2, Br J Pharmacol
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- BACKGROUND AND PURPOSE: Chloroquine is a traditional medicine to treat malaria. There is increasing evidence that chloroquine not only induces phagocytosis but regulates vascular tone. Few reports investigating the effect of chloroquine on vascular responsiveness of coronary arteries have been made. In this study, we examined how chloroquine affected endothelium‐dependent relaxation in coronary arteries under normal and diabetic conditions. EXPERIMENTAL APPROACH: We isolated coronary arteries from mice and examined endothelium‐dependent relaxation (EDR). Human coronary endothelial cells and mouse coronary endothelial cells isolated from control and diabetic mouse (TALLYHO/Jng [TH] mice, a spontaneous type 2 diabetic mouse model) were used for the molecular biological or cytosolic NO and Ca(2+) measurements. KEY RESULTS: Chloroquine inhibited endothelium‐derived NO‐dependent relaxation but had negligible effect on endothelium‐derived hyperpolarization (EDH)‐dependent relaxation in coronary arteries of control mice. Chloroquine significantly decreased NO production in control human coronary endothelial cells partly by phosphorylating eNOS(Thr495) (an inhibitory phosphorylation site of eNOS) and attenuating the rise of cytosolic Ca(2+) concentration after stimulation. EDR was significantly inhibited in diabetic mice in comparison to control mice. Interestingly, chloroquine enhanced EDR in diabetic coronary arteries by, specifically, increasing EDH‐dependent relaxation due partly to its augmenting effect on gap junction activity in diabetic mouse coronary endothelial cells. CONCLUSIONS AND IMPLICATIONS: These data indicate that chloroquine affects vascular relaxation differently under normal and diabetic conditions. Therefore, the patients' health condition such as coronary macrovascular or microvascular disease, with or without diabetes, must be taken account into the consideration when selecting chloroquine for the treatment of malaria.
- Subjects :
- Male
0301 basic medicine
Vasodilator Agents
Vasodilation
Stimulation
Inbred C57BL
Cardiovascular
Mice
0302 clinical medicine
Enos
Chloroquine
Pharmacology & Pharmacy
Phosphorylation
biology
Diabetes
Gap Junctions
Pharmacology and Pharmaceutical Sciences
Hyperpolarization (biology)
Research Papers
Coronary Vessels
Heart Disease
medicine.anatomical_structure
Type 2
medicine.drug
medicine.medical_specialty
Nitric Oxide Synthase Type III
Phagocytosis
Nitric Oxide
Antimalarials
03 medical and health sciences
Vascular
Internal medicine
Diabetes mellitus
Diabetes Mellitus
medicine
Animals
Humans
Endothelium
Calcium Signaling
Heart Disease - Coronary Heart Disease
Metabolic and endocrine
Pharmacology
Animal
business.industry
biology.organism_classification
medicine.disease
Mice, Inbred C57BL
Coronary arteries
Disease Models, Animal
Good Health and Well Being
030104 developmental biology
Endocrinology
Diabetes Mellitus, Type 2
Disease Models
Endothelium, Vascular
business
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- ISSN :
- 14765381 and 00071188
- Database :
- OpenAIRE
- Journal :
- British Journal of Pharmacology
- Accession number :
- edsair.doi.dedup.....ba8b3405f9fb060c0ecb814cf27c11ad
- Full Text :
- https://doi.org/10.1111/bph.14864